《Chinese Journal of Rehabilitation Theory and Practice》

Previous Articles     Next Articles

Pathogen of Pulmonary Infection in Patients with Cervical Spinal Cord Injury and Antibiotics Therapy

ZHAO Guo-wei, GAO Jun   

  1. Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing 100068, China
  • Published:2016-07-25 Online:2016-09-22

Abstract: Objective To investigate the distribution and drug resistance of pathogen for pulmonary infection in cervical spinal cord injury (CSCI) patients, and analyze the application of antibiotics. Methods From January, 2014 to June, 2015, 156 patients with CSCI were reviewed. The bacteriology and drug resistance were investigated, as well as the application of antibiotics. Results There were 45 cases with nosocomial infection of 68 times, and 106 strains of bacteria in total. The top four Gram-negative pathogens were Klebsiella pneumonia (17.9%), Pseudomonas aeruginosae (15.1%), Encherichia coli (11.3%) and Acinetobacter baumannii (8.5%). The main Gram-positive cocci was Staphylococcus aureus (9.4%), and the main fungi was Candida tropicalis (0.7%). Gram-negative bacteria was resistant to the second or third generation cephalosporins and quinolones moderately or severely, but sensitive to β-lactamase inhibitor combinations and aminoglycosides. The main Gram-positive cocci were sensitive to vancomycin. The application of antibiotics needed to be improved. Conclusion The Gram-negative bacteria are the chief pathogen for pulmonary infection in CSCI patients, which show multiple drug-resistant. It is significant to monitor the drug resistance of bacteria and optimize antibiotics.

Key words: cervical spinal cord injury, pulmonary infection, pathogens, drug-resistant, antibiotics